506 related articles for article (PubMed ID: 27525434)
1. Hypoxia-inducible factors: a central link between inflammation and cancer.
Triner D; Shah YM
J Clin Invest; 2016 Oct; 126(10):3689-3698. PubMed ID: 27525434
[TBL] [Abstract][Full Text] [Related]
2. The ever-expanding role of HIF in tumour and stromal biology.
LaGory EL; Giaccia AJ
Nat Cell Biol; 2016 Apr; 18(4):356-65. PubMed ID: 27027486
[TBL] [Abstract][Full Text] [Related]
3. Epithelial Hypoxia-Inducible Factor 2α Facilitates the Progression of Colon Tumors through Recruiting Neutrophils.
Triner D; Xue X; Schwartz AJ; Jung I; Colacino JA; Shah YM
Mol Cell Biol; 2017 Mar; 37(5):. PubMed ID: 27956697
[TBL] [Abstract][Full Text] [Related]
4. Emerging roles of hypoxia-inducible factors and reactive oxygen species in cancer and pluripotent stem cells.
Saito S; Lin YC; Tsai MH; Lin CS; Murayama Y; Sato R; Yokoyama KK
Kaohsiung J Med Sci; 2015 Jun; 31(6):279-86. PubMed ID: 26043406
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia-inducible factors: crosstalk between inflammation and metabolism.
Shay JE; Celeste Simon M
Semin Cell Dev Biol; 2012 Jun; 23(4):389-94. PubMed ID: 22525300
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia-inducible factors as key regulators of tumor inflammation.
Mamlouk S; Wielockx B
Int J Cancer; 2013 Jun; 132(12):2721-9. PubMed ID: 23055435
[TBL] [Abstract][Full Text] [Related]
7. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway.
Blancher C; Moore JW; Robertson N; Harris AL
Cancer Res; 2001 Oct; 61(19):7349-55. PubMed ID: 11585776
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia-inducible factors and innate immunity in liver cancer.
Yuen VW; Wong CC
J Clin Invest; 2020 Oct; 130(10):5052-5062. PubMed ID: 32750043
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia inducible factor (HIF) in the tumor microenvironment: friend or foe?
Huang Y; Lin D; Taniguchi CM
Sci China Life Sci; 2017 Oct; 60(10):1114-1124. PubMed ID: 29039125
[TBL] [Abstract][Full Text] [Related]
10. The hypoxia-adenosine link during inflammation.
Bowser JL; Lee JW; Yuan X; Eltzschig HK
J Appl Physiol (1985); 2017 Nov; 123(5):1303-1320. PubMed ID: 28798196
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer.
Wigerup C; Påhlman S; Bexell D
Pharmacol Ther; 2016 Aug; 164():152-69. PubMed ID: 27139518
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia-mediated drug resistance: novel insights on the functional interaction of HIFs and cell death pathways.
Rohwer N; Cramer T
Drug Resist Updat; 2011 Jun; 14(3):191-201. PubMed ID: 21466972
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia inducible factor-1 independent pathways in tumor angiogenesis.
Mizukami Y; Kohgo Y; Chung DC
Clin Cancer Res; 2007 Oct; 13(19):5670-4. PubMed ID: 17908955
[TBL] [Abstract][Full Text] [Related]
14. HIF-1alpha and HIF-2alpha are differentially regulated in vivo in neuroblastoma: high HIF-1alpha correlates negatively to advanced clinical stage and tumor vascularization.
Noguera R; Fredlund E; Piqueras M; Pietras A; Beckman S; Navarro S; Påhlman S
Clin Cancer Res; 2009 Dec; 15(23):7130-6. PubMed ID: 19903792
[TBL] [Abstract][Full Text] [Related]
15. Targeting tumour angiogenesis with small molecule inhibitors of hypoxia inducible factor.
Nordgren IK; Tavassoli A
Chem Soc Rev; 2011 Aug; 40(8):4307-17. PubMed ID: 21483947
[TBL] [Abstract][Full Text] [Related]
16. Relationship of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha expression to vascular endothelial growth factor induction and hypoxia survival in human breast cancer cell lines.
Blancher C; Moore JW; Talks KL; Houlbrook S; Harris AL
Cancer Res; 2000 Dec; 60(24):7106-13. PubMed ID: 11156418
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia inducible factor 1α and hypoxia inducible factor 2α play distinct and functionally overlapping roles in oral squamous cell carcinoma.
Zhu GQ; Tang YL; Li L; Zheng M; Jiang J; Li XY; Chen SX; Liang XH
Clin Cancer Res; 2010 Oct; 16(19):4732-41. PubMed ID: 20807755
[TBL] [Abstract][Full Text] [Related]
18. Opposite functions of HIF-α isoforms in VEGF induction by TGF-β1 under non-hypoxic conditions.
Chae KS; Kang MJ; Lee JH; Ryu BK; Lee MG; Her NG; Ha TK; Han J; Kim YK; Chi SG
Oncogene; 2011 Mar; 30(10):1213-28. PubMed ID: 21057546
[TBL] [Abstract][Full Text] [Related]
19. Tanshinone IIA inhibits β-catenin/VEGF-mediated angiogenesis by targeting TGF-β1 in normoxic and HIF-1α in hypoxic microenvironments in human colorectal cancer.
Sui H; Zhao J; Zhou L; Wen H; Deng W; Li C; Ji Q; Liu X; Feng Y; Chai N; Zhang Q; Cai J; Li Q
Cancer Lett; 2017 Sep; 403():86-97. PubMed ID: 28602978
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia inducible factors 1alpha and 2alpha are associated with VEGF expression and angiogenesis in gallbladder carcinomas.
Giatromanolaki A; Sivridis E; Simopoulos C; Polychronidis A; Gatter KC; Harris AL; Koukourakis MI
J Surg Oncol; 2006 Sep; 94(3):242-7. PubMed ID: 16900513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
